Results 181 to 190 of about 666,764 (304)
Visceral Obesity as a Predictor of Clinical Relapse in Inflammatory Bowel Disease. [PDF]
Hasnol H, Tan J, Jain T, Subramaniam K.
europepmc +1 more source
Abstract The increasing prevalence of obesity has transformed intensive care and nutritional therapy of patients with obesity from a specialized problem to standard care. The dilemma in providing nutrition to critically ill patients with obesity is that current and historical nutritional guideline recommendations are based on expert opinion, are ...
K. Georg Kreymann +2 more
wiley +1 more source
The role of visceral obesity surrogate markers in predicting cardiovascular disease: Insights from the CHARLS study. [PDF]
Guo P, Liu Y, Chen G, Jiang Y.
europepmc +1 more source
ABSTRACT Objective BMI is widely used to define obesity and may not capture heterogeneity in body fat distribution. Genetic studies of obesity have largely focused on BMI but not visceral fat and fat‐free mass, which is particularly limited in East Asian populations.
Hsin‐Ming Lu +5 more
wiley +1 more source
Association of visceral obesity with Helicobacter pylori seropositivity and mortality in US adults. [PDF]
Liu ZQ +6 more
europepmc +1 more source
ABSTRACT Objective We aimed to understand the global burden of obesity in early adulthood and later adulthood over the past three decades. Methods We analyzed obesity prevalence across 196 countries/territories from 1990 to 2022 for early adulthood (age 20–49 years) and later adulthood (age ≥ 50 years) using the Non‐Communicable Disease Risk Factor ...
Abdiwahab M. Ali +2 more
wiley +1 more source
Associations of novel visceral obesity indices (METS-VF and BRI) with dementia: the role of metabolic mediators and genetic susceptibility. [PDF]
Xue X +9 more
europepmc +1 more source
ABSTRACT Objective BMI alone does not capture obesity‐related health heterogeneity. The Edmonton Obesity Staging System (EOSS) grades obesity severity based on comorbidities and functional impairment, whereas the Lancet Commission Diagnostic Model for Obesity (DMO) distinguishes preclinical from clinical obesity based on organ dysfunction.
Tobias Hagemann +3 more
wiley +1 more source
Association of Visceral Obesity Indices With Survival Among Cancer Survivors: Evidence From Two Nationally Population-Based Cohort Study. [PDF]
Li Q, Wang Y, Liu Q, Zhang W.
europepmc +1 more source
The role of tryptophan hydroxylase‐1 in metabolic dysfunction‐associated steatotic liver disease
Silencing hepatic tryptophan hydroxylase 1 (TPH1) alleviated diet‐induced steatotic liver disease by reducing lipid accumulation, oxidative stress, inflammation, fibrosis, and hepatocyte apoptosis. These protective effects were mediated, at least in part, through restoration of Parkin‐dependent mitochondrial autophagy, identifying hepatic TPH1 as a ...
Shuangzhen Jia +3 more
wiley +1 more source

